Acquisition time: A key point of hepatitis C virusrelated liver disease in renal transplant recipients

References (9)

1. Ruhi Ç, Süleymanlar ‹, Koçak H, et al. The impact of hepatitis C virus infection on long-term outcome in renal transplant patients. Turk J Gastroenterol 2011; 22: 165-70
2. Breitenfeldt MK, Rasenack J, Berthold H, et al. Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation. Clin Transplant 2002; 16: 130- 6
3. Ynares C, Johnson HK, Kerlin T, et al. Impact of pretransplant hepatitis C antibody status upon long-term patient and renal allograft survival: a 5- and 10-year follow-up. Transplant Proc 1993; 25: 1466-8
4. Periera BJ, Wright TL, Schmid CH, Levey AS. The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation. Transplantation 1995; 60: 779- 805
5. Legendre C, Garrigue V, Le Bihan C, et al. Harmful longterm impact of hepatitis C virus infection in kidney transplant recipients. Transplantation 1998; 65: 667-70
6. Töz H, Nart D, Turan ‹, et al. The acquisition time of infection: a determinant of the severity of hepatitis C virus-related liver disease in renal transplant patients. Clin Transplant 2009; 23: 723-31
7. Ong JP, Barnes SD, Younissi ZM, et al. Outcome of de novo hepatitis C virus infection in heart transplant patients. Hepatology 1999; 30: 1293-8
8. File E, Mehra M, Nair S, et al. Allograft transmission of hepatitis C virus infection from infected donors in cardiac transplantation. Transplantation 2003; 76: 1096-100
9. Dienstag JL, McHutchison JG. American Gastroenterological Association technical review on the management of hepatitis C. Gastroenterology 2006; 130: 231-64.